Survival-associated factors of first-line EGFR-tyrosine kinase inhibitor responders and non-responders in lung adenocarcinoma patients with common EGFR mutations

Samankaltaisia teoksia

• The content of mutant EGFR DNA correlates with response to EGFR-TKIs in lung adenocarcinoma patients with common EGFR mutations
  Tekijä: Hung, Ming-Szu, et al.
  Julkaistu: (2016)
• Comparative Analysis of Two Methods for the Detection of EGFR Mutations in Plasma Circulating Tumor DNA from Lung Adenocarcinoma Patients
  Tekijä: Hung, Ming-Szu, et al.
  Julkaistu: (2019)
• The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
  Tekijä: Wu, Shang-Gin, et al.
  Julkaistu: (2016)
• EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas
  Tekijä: Chen, Zhi-Yong, et al.
  Julkaistu: (2012)
• A combined subtype of small cell lung cancer and adenocarcinoma with epidermal growth factor receptor (EGFR) mutation responds to EGFR tyrosine kinase inhibitors
  Tekijä: Zhang, Yong, et al.
  Julkaistu: (2018)